|
Current Active Clinical Research in Japan |
|||
|
Clinical Research Subject (Study ID) |
Site Name |
Study Protocol |
Actual Funding to Date |
| PD001J | Shonan Fujisawa Tokushukai Hospital |
A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound for Unilateral Thalamotomy in the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson’s Disease. |
7,700.000 |
| PD002J | Shonan Fujisawa Tokushukai Hospital Hokuto Hospital |
A Feasibility Clinical Trial of the Management of the Medically-Refractory Dyskinesia Symptoms of Advanced Idiopathic Parkinson’s Disease With Unilateral Lesioning of the Globus Pallidum Using the ExAblate Transcranial System. |
3,300.000 8,800.000 |
| PD005 | Tokyo Metropolitan Neurological Hospital Shin-Yurigaoka General Hospital |
Feasibility Study to Evaluate the Safety and Effectiveness of Bilateral Magnetic Resonance-guided Focused Ultrasound (MRgFUS) Ablation of the Pallido-Thalamic Tract for the Treatment of Advanced Parkinson’s Disease |
1,700.000 |
| ET003 | Osaka University Hospital Saito Yukoukai Hospital |
A Clinical Trial to Evaluate the Safety and Efficacy of Staged Bilateral ExAblate Treatment of Medication Refractory Essential Tremor |
400,000 11,600.000 |
| ET002J | Osaka University Hospital Saito Yukoukai Hospital |
A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects. |
|
| Tokyo Women’s Medical University Hospital |
A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects. |
||
| Hokkaido Ohno Memorial Hospital |
A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects. |
||
| Hokuto Hospital |
A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects. |
1,000.000 | |
| Kumagaya General Hospital |
A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects. |
11,600.000 |
|
| Shonan Fujisawa Tokushukai Hospital |
A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects. |
13,900.000 |
|
| Ohnishi Neurological Center |
A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects. |
11,176.000 |
|
| Sadamoto Hospital |
A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects. |
16,000.000 |
|
| ND001 | Ohnishi Neurological Center |
Global Registry: ExAblate 4000 Transcranial MR Guided Focused Ultrasound of Neurological Disorders: Essential Tremor, Tremor Dominant Idiopathic Parkinson’s Disease, and Neuropathic Pain. |
|
| Sadamoto Hospital |
Global Registry: ExAblate 4000 Transcranial MR Guided Focused Ultrasound of Neurological Disorders: Essential Tremor, Tremor Dominant Idiopathic Parkinson’s Disease, and Neuropathic Pain. |
||
| Nagoya Kyoritsu Hospital |
Global Registry: ExAblate 4000 Transcranial MR Guided Focused Ultrasound of Neurological Disorders: Essential Tremor, Tremor Dominant Idiopathic Parkinson’s Disease, and Neuropathic Pain. |
||
| PMS001 | Hokkaido Ohno Memorial Hospital |
Post Market Survey for ExAblate 4000 |
|
| Hokuto Hospital |
Post Market Survey for ExAblate 4000 |
||
| Kumagaya General Hospital |
Post Market Survey for ExAblate 4000 |
||
| Shonan Fujisawa Tokushukai Hospital |
Post Market Survey for ExAblate 4000 |
||
| Ohnishi Neurological Center |
Post Market Survey for ExAblate 4000 |
||
| Sadamoto Hospital |
Post Market Survey for ExAblate 4000 |
||
| Nagoya Kyoritsu Hospital |
Post Market Survey for ExAblate 4000 |
||
| Shonan Fujisawa Tokushukai Hospital |
Post Market Survey for ExAblate 4000 |
||